ClinicalTrials.Veeva

Menu

FDG PET-Scan Analysis of Evolutivity of Non-surgical Aneurysm of Abdominal Aorta (AAA)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Medically-treated Aneurysm of Abdominal Aorta

Treatments

Other: PET-Scan

Study type

Interventional

Funder types

Other

Identifiers

NCT02182908
2006-004852-19

Details and patient eligibility

About

The primary aim of the study is to determine if the evolutivity of global and segmentary captation of FDG-F18, which can be measured in the wall of abdominal aorta aneurysm, is predictive of the 9 month evolution of diameter and volume of the aneurysm, measured globally and segmentary in angioscan.

Enrollment

51 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • AAA with a minimum diameter of 40 mm, calculated with a standardized method
  • No indication for an immediate surgery or endoprothesis implantation
  • Age above 18 (except for patient under supervision)
  • Patient having read the information letter and signed the informed consent

Exclusion criteria

  • AAA should have no other specific cause than atherosclerosis

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

51 participants in 1 patient group

Non surgical aneurysm of abdominal aorta
Other group
Description:
PET-Scan
Treatment:
Other: PET-Scan

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems